Global Angiogenesis Assay Market Growth (Status and Outlook) 2025-2031

Global Angiogenesis Assay Market Growth (Status and Outlook) 2025-2031

The global Angiogenesis Assay market size is predicted to grow from US$ 20.4 million in 2025 to US$ 32.6 million in 2031; it is expected to grow at a CAGR of 8.1% from 2025 to 2031.

Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.

Global Angiogenesis Assay key players include Abcam, Bio-Techne, Thermo Fisher Scientific, PromoCell GmbH, Merck KGaA, etc. Global top five manufacturers hold a share over 65%.

North America is the largest market, with a share over 35%, followed by Europe and Asia Pacific, both have a share nearly 60 percent. In terms of product, In Vitro Assay Kit is the largest segment, with a share over 95%. And in terms of application, the largest application is Academic Institution, followed by Biotech Companies, etc.

LPI (LP Information)' newest research report, the “Angiogenesis Assay Industry Forecast” looks at past sales and reviews total world Angiogenesis Assay sales in 2024, providing a comprehensive analysis by region and market sector of projected Angiogenesis Assay sales for 2025 through 2031. With Angiogenesis Assay sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Angiogenesis Assay industry.

This Insight Report provides a comprehensive analysis of the global Angiogenesis Assay landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Angiogenesis Assay portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Angiogenesis Assay market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Angiogenesis Assay and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Angiogenesis Assay.

This report presents a comprehensive overview, market shares, and growth opportunities of Angiogenesis Assay market by product type, application, key players and key regions and countries.

Segmentation by Type:
In Vitro Assay Kit
In Vivo Assay Kit

Segmentation by Application:
Academic Institution
Biotech Companies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abcam
Bio-Techne
Thermo Fisher Scientific
Cell Biolabs, Inc.
BioVision, Inc
PromoCell GmbH
Merck KGaA
Kollodis BioSciences
Sartorius (Essen BioScience)
Creative Bioarray

Please note: The report will take approximately 2 business days to prepare and deliver.